Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Elevance Health, Inc.ANTM · Entity 2934 | EVP & General Counsel | November 03, 2020 | November 04, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Elevance Health, Inc.
Report date November 03, 2020 · Filed November 04, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,910 |
Ending reported balance
After 2020-11-03 transaction · row 5
5 source rows · reconciled sequenceRow 1 · 2020-11-03 · Sale · Disposed 4,780 · Balance 20,412 F1: This transaction was executed in multiple trades at prices ranging from $291.58 to $292.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 2 · 2020-11-03 · Sale · Disposed 2 · Balance 20,410 F2: This transaction was executed in multiple trades at prices ranging from $292.61 to $292.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Row 3 · 2020-11-03 · Sale · Disposed 2,500 · Balance 17,910 Row 4 · 2020-11-03 · Exercise / conversion · Acquired 1,893 · Balance 19,803 Row 5 · 2020-11-03 · Sale · Disposed 1,893 · Balance 17,910 |
| Employee Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $232.04 · Expires 2028-03-01 | Direct | 1,893 |
Reported balance
After 2020-11-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2020-11-03 · Exercise / conversion · Disposed 1,893 · Balance 1,893 F3: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was executed in multiple trades at prices ranging from $291.58 to $292.54. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: This transaction was executed in multiple trades at prices ranging from $292.61 to $292.66. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 5,104 | $166.97 | $852,214.88 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,539 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 6,763 | $131.80 | $891,363.40 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,435 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 5,588 | $146.93 | $821,044.84 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,672 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 13, 2018 Filed Mar 15, 2018 20:30 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 3,000 | $108.35 | $325,050.00 |
DisclosureSEC source: 0001127602-18-011705 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,084 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:54 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 12,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010119 · form4.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,084 F3 · shares: Represents performance based restricted share units. Restrictions lapsed on 3/2/18. Read SEC document |
| March 02, 2018 Filed Mar 5, 2018 21:54 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 5,482 | $233.08 | $1,277,744.56 |
DisclosureSEC source: 0001127602-18-010119 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,856 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:54 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,354 | $0.00 Strike: $232.04 | $0.00 |
DisclosureSEC source: 0001127602-18-010119 · form4.xml · derivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,354 Underlying: Common Stock · 11,354 shares Expires 2028-03-01 F4 · derivative.exercise_date: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:54 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 2,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-18-010119 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,338 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 898 shares each on 3/1/2019, 3/1/2020 and 3/1/2021. Read SEC document |
| March 01, 2018 Filed Mar 5, 2018 21:54 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 800 | $232.04 | $185,632.00 |
DisclosureSEC source: 0001127602-18-010119 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,644 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 20:37 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 9,127 | $0.00 Strike: $108.35 | $0.00 |
DisclosureSEC source: 0001127602-17-025502 · form4.xml · derivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,064 Underlying: Common Stock · 9,127 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on 12/2/14, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 20:37 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,000 | $192.76 | $192,760.00 |
DisclosureSEC source: 0001127602-17-025502 · form4.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,444 F2 · shares: This transaction was executed in multiple trades at prices ranging from $192.53 to $192.95. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 20:37 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 5,027 | $191.82 | $964,279.14 |
DisclosureSEC source: 0001127602-17-025502 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,444 F1 · shares: This transaction was executed in multiple trades at prices ranging from $191.50 to $192.48. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 20:37 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 3,100 | $189.85 | $588,535.00 |
DisclosureSEC source: 0001127602-17-025502 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,471 Read SEC document |
| August 10, 2017 Filed Aug 11, 2017 20:37 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 9,127 | $108.35 | $988,910.45 |
DisclosureSEC source: 0001127602-17-025502 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,571 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2017 Filed Jun 5, 2017 20:02 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 3,071 | $187.58 | $576,058.18 |
DisclosureSEC source: 0001127602-17-020495 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,444 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 11,174 | $0.00 Strike: $146.93 | $0.00 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · derivative · entry 12 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,588 Underlying: Common Stock · 11,174 shares Expires 2025-03-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option represents a right to purchase a total of 16,762 shares, and is exercisable in six semi annual installments with two installments of 2,793 shares each and four installments of 2,794 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,762 | $0.00 Strike: $131.80 | $0.00 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · derivative · entry 11 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,527 Underlying: Common Stock · 6,762 shares Expires 2026-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $108.35 | $0.00 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · derivative · entry 10 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,191 Underlying: Common Stock · 5,000 shares Expires 2021-06-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The option represents a right to purchase a total of 21,191 shares, and is exercisable in six semi-annual installments with one installment of 3,531 shares and five installments of 3,532 shares each beginning on 12/2/14, which is the six-month anniversary of the date on which the option was granted. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 605 | $165.97 | $100,411.85 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 8 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,515 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 1,028 | $166.75 | $171,419.00 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 7 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,120 F4 · shares: This transaction was executed in multiple trades at prices ranging from $166.74 to $166.78. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | SaleCommon Stock | 21,908 | $166.27 | $3,642,643.16 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 6 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,148 F3 · shares: This transaction was executed in multiple trades at prices ranging from $165.74 to $166.73. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 11,174 | $146.93 | $1,641,795.82 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 5 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 6,762 | $131.80 | $891,231.60 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 4 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Exercise / conversionCommon Stock | 5,000 | $108.35 | $541,750.00 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 3 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,120 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantEmployee Stock Option (Right to Buy) · Derivative | 15,314 | $0.00 Strike: $166.97 | $0.00 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · derivative · entry 9 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,314 Underlying: Common Stock · 15,314 shares Expires 2027-03-01 F5 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | GrantCommon Stock | 3,744 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 2 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,120 F2 · shares: Represents restricted share units. Restrictions lapse as follows: 1,248 shares each on 3/1/2018, 3/1/2019 and 3/1/2020. Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 21:24 UTC | Elevance Health, Inc. ANTM · Entity 2934 | Tax withholdingCommon Stock | 559 | $166.97 | $93,336.23 |
DisclosureSEC source: 0001127602-17-010158 · form4.xml · nonDerivative · entry 1 ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,376 F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.